154 related articles for article (PubMed ID: 34950631)
1. Carbon Ion Radiotherapy Evokes a Metabolic Reprogramming and Individualized Response in Prostate Cancer.
Ning R; Pei Y; Li P; Hu W; Deng Y; Hong Z; Sun Y; Zhang Q; Guo X
Front Public Health; 2021; 9():777160. PubMed ID: 34950631
[No Abstract] [Full Text] [Related]
2. Carbon Ion Radiotherapy Induce Metabolic Inhibition After Functional Imaging-Guided Simultaneous Integrated Boost for Prostate Cancer.
Pei Y; Ning R; Hu W; Li P; Zhang Z; Deng Y; Hong Z; Sun Y; Guo X; Zhang Q
Front Oncol; 2022; 12():845583. PubMed ID: 35936669
[TBL] [Abstract][Full Text] [Related]
3. The metabolic repression effect of carbon-ion radiotherapy in synchronous hormone-sensitive oligometastatic prostate cancer.
Zhang Z; Pei Y; Hu W; Xue Y; Ning R; Guo X; Sun Y; Zhang Q
Front Endocrinol (Lausanne); 2023; 14():1291653. PubMed ID: 38027094
[TBL] [Abstract][Full Text] [Related]
4. Biological and clinical significance of radiomics features obtained from magnetic resonance imaging preceding pre-carbon ion radiotherapy in prostate cancer based on radiometabolomics.
Zhang G; Zhang Z; Pei Y; Hu W; Xue Y; Ning R; Guo X; Sun Y; Zhang Q
Front Endocrinol (Lausanne); 2023; 14():1272806. PubMed ID: 38027108
[TBL] [Abstract][Full Text] [Related]
5. Immunomodulatory effects of carbon ion radiotherapy in patients with localized prostate cancer.
Hu W; Pei Y; Ning R; Li P; Zhang Z; Hong Z; Bao C; Guo X; Sun Y; Zhang Q
J Cancer Res Clin Oncol; 2023 Jul; 149(8):4533-4545. PubMed ID: 36138265
[TBL] [Abstract][Full Text] [Related]
6. Conversion and validation of rectal constraints for prostate carcinoma receiving hypofractionated carbon-ion radiotherapy with a local effect model.
Wang W; Li P; Sheng Y; Huang Z; Zhao J; Hong Z; Shahnazi K; Jiang GL; Zhang Q
Radiat Oncol; 2021 Apr; 16(1):72. PubMed ID: 33849589
[TBL] [Abstract][Full Text] [Related]
7. Nano-Vesicles are a Potential Tool to Monitor Therapeutic Efficacy of Carbon Ion Radiotherapy in Prostate Cancer.
Yu Q; Li P; Weng M; Wu S; Zhang Y; Chen X; Zhang Q; Shen G; Ding X; Fu S
J Biomed Nanotechnol; 2018 Jan; 14(1):168-178. PubMed ID: 29463374
[TBL] [Abstract][Full Text] [Related]
8. Carbon ion radiotherapy for prostate cancer with bladder invasion.
Miyasaka Y; Kawamura H; Sato H; Kubo N; Mizukami T; Matsui H; Miyazawa Y; Ito K; Nakano T; Suzuki K; Ohno T
BMC Urol; 2021 Aug; 21(1):106. PubMed ID: 34362355
[TBL] [Abstract][Full Text] [Related]
9. The predictive role of ADC values in prostate cancer patients treated with carbon-ion radiotherapy: initial clinical experience at Shanghai Proton and Heavy Ion Center (SPHIC).
Qi WX; Zhang Q; Li P; Zhang XM; Zhang GY; Wu B; Lu JJ; Jiang GL; Fu S
J Cancer Res Clin Oncol; 2016 Jun; 142(6):1361-7. PubMed ID: 27008005
[TBL] [Abstract][Full Text] [Related]
10. MRI response of obturator internus muscle to carbon-ion dose in prostate cancer treatment.
Kawahara M; Kawamura H; Kubota Y; Katoh H; Kubo N; Shimada H; Torikai K; Torikoshi M; Kanai T; Nakano T
J Radiat Res; 2019 May; 60(3):335-341. PubMed ID: 30668869
[TBL] [Abstract][Full Text] [Related]
11. Imaging-Based Individualized Response Prediction Of Carbon Ion Radiotherapy For Prostate Cancer Patients.
Wu S; Jiao Y; Zhang Y; Ren X; Li P; Yu Q; Zhang Q; Wang Q; Fu S
Cancer Manag Res; 2019; 11():9121-9131. PubMed ID: 31695500
[TBL] [Abstract][Full Text] [Related]
12. Monte Carlo study of out-of-field exposure in carbon-ion radiotherapy with a passive beam: Organ doses in prostate cancer treatment.
Yonai S; Matsufuji N; Akahane K
Phys Med; 2018 Jul; 51():48-55. PubMed ID: 29699921
[TBL] [Abstract][Full Text] [Related]
13. The relative biological effectiveness of carbon ion radiation therapy for early stage lung cancer.
Jeong J; Taasti VT; Jackson A; Deasy JO
Radiother Oncol; 2020 Dec; 153():265-271. PubMed ID: 32976878
[TBL] [Abstract][Full Text] [Related]
14. Secondary cancers after carbon-ion radiotherapy and photon beam radiotherapy for uterine cervical cancer: A comparative study.
Nitta Y; Murata H; Okonogi N; Murata K; Wakatsuki M; Karasawa K; Kato S; Yamada S; Nakano T; Tsuji H
Cancer Med; 2022 Jun; 11(12):2445-2454. PubMed ID: 35318825
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of carbon-ion radiotherapy versus stereotactic body radiotherapy for non-small-cell lung cancer.
Okazaki S; Shibuya K; Takura T; Miyasaka Y; Kawamura H; Ohno T
Cancer Sci; 2022 Feb; 113(2):674-683. PubMed ID: 34820994
[TBL] [Abstract][Full Text] [Related]
16. ADC value and diffusion tensor imaging of prostate cancer: changes in carbon-ion radiotherapy.
Takayama Y; Kishimoto R; Hanaoka S; Nonaka H; Kandatsu S; Tsuji H; Tsujii H; Ikehira H; Obata T
J Magn Reson Imaging; 2008 Jun; 27(6):1331-5. PubMed ID: 18504751
[TBL] [Abstract][Full Text] [Related]
17. Preliminary exploration of clinical factors affecting acute toxicity and quality of life after carbon ion therapy for prostate cancer.
Zhang Y; Li P; Yu Q; Wu S; Chen X; Zhang Q; Fu S
Radiat Oncol; 2019 Jun; 14(1):94. PubMed ID: 31164172
[TBL] [Abstract][Full Text] [Related]
18. Health Technology Assessment of Carbon-ion Beam Radiotherapy: A Systematic Review of Clinical Effectiveness and Safety for 54 Oncological Indications in 12 Tumour Regions.
Goetz G; Mitic M; Mittermayr T; Wild C
Anticancer Res; 2019 Apr; 39(4):1635-1650. PubMed ID: 30952702
[TBL] [Abstract][Full Text] [Related]
19. Phase I/II trial evaluating concurrent carbon-ion radiotherapy plus chemotherapy for salvage treatment of locally recurrent nasopharyngeal carcinoma.
Kong L; Gao J; Hu J; Hu W; Guan X; Lu R; Lu JJ
Chin J Cancer; 2016 Dec; 35(1):101. PubMed ID: 28007028
[TBL] [Abstract][Full Text] [Related]
20. Autophagy Inhibition Increased Sensitivity of Pancreatic Cancer Cells to Carbon Ion Radiotherapy.
Sudo M; Tsutsui H; Hayashi S; Yasuda K; Mitani K; Iwami N; Anzai M; Tsubouchi T; Ishida M; Satoi S; Kanai T; Hirono S; Hatano E; Fujimoto J
Cell Physiol Biochem; 2023 Jul; 57(4):212-225. PubMed ID: 37463410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
